why choose us

Clinical Trials Search

Showing 3,410 of 132,963 result(s)
Oral Health and Endometriosis: A Cohort Study

Status: COMPLETED

Condition: Endometriosis

Interventions:

Date: 2024-12-18

An Observational Study to Gather Real-World User Feedback on DIPROBASE® Advanced Eczema Cream in Adults and Children With Eczema or Dry Skin

Status: COMPLETED

Condition: Dermatitis, Atopic

Interventions: Product experience is assessed based on the answers provided by participants on the questions provided to them using an online questionnaire.

Date: 2024-12-18

Early Outcomes of Arthroscopic Versus Open Reduction for Developmental Dysplasia of the Hip in Children

Status: COMPLETED

Condition: Developmental Dysplasia of the Hip (DDH)

Interventions: Arthroscopy

Date: 2024-12-18

Comparison of Three Treatment in Children With Cerebral Palsy

Status: COMPLETED

Condition: Cerebral Palsy

Interventions: In addition to the neurodevelopmental treatment of 30 minutes per day, 3 sessions per week, and a total of 24 sessions, core stabilization training wa

Date: 2024-12-18

Real-World Immuno-Radiotherapy for Advanced NSCLC

Status: COMPLETED

Condition: Lung Cancer Non-Small Cell Cancer (NSCLC)

Interventions:

For unresectable locally advanced NSCLC, definitive thoracic radiotherapy must have been administered as the initial treatment, with immunotherapy

Date: 2024-12-18

The Gender-Specific Effect of Different Instruction Training

Status: COMPLETED

Condition: Sports Injury

Interventions: "Pre-test" measurements were taken to determine the baseline values of the athletes before the training packages specific to their group.

Date: 2024-12-18

Examining the Efficacy of a Newly Developed Smoking Cessation Program

Status: COMPLETED

Condition: Nicotine Addiction

Interventions: Lifestyle modifications based on the Quit Center cessation program.

Date: 2024-12-18

A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease

Status: COMPLETED

Condition: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: DRUG: TQC3721 inhalation powder - TQC3721 is a target inhibitor.
DRUG: Placebo for TQC3721 inhalation powder - Placebo without drug substance.

Date: 2024-12-18